BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 7, 2018
View Archived Issues
Eisai reviews milestones of third quarter of fiscal 2017
Read More
Pembrolizumab plus rhuGM-CSF found safe in patients with advanced biliary cancer
Read More
FDA gives RMAT designation to Capricor's CAP-1002 for DMD
Read More
Dose modification on MM-398 plus 5-FU/LV does not impact survival
Read More
Silver Creek Pharmaceuticals completes financing to advance SGF-1
Read More
IND for anti-PD-L1 antibody STI-A1015 cleared in South Korea
Read More
Mitsubishi Tanabe Pharma reviews developments of third quarter of fiscal 2017
Read More
Positive topline phase III results from ACHIEVE I study of ubrogepant
Read More
Topline data presented from phase II study of NGM-282 in primary sclerosing cholangitis
Read More
Servier and ImmunoQure to collaborate on the development of an interferon-alpha human autoantibody
Read More
Zogenix's ZX-008 granted FDA breakthrough therapy designation
Read More
First patient treated in phase II study of Imprime PGG in combination with Keytruda
Read More
Novel PAR-4 antagonists discovered at Bristol-Myers Squibb
Read More
Bavarian Nordic reports results from phase III pivotal study of smallpox vaccine
Read More
Actinium to study Actimab-A with CLAG-M in relapsed or refractory AML
Read More
Lifesci Pharmaceuticals discloses new plasma kallikrein inhibitors
Read More
Bioway describes novel PI3Kdelta/PI3Kgamma inhibitors
Read More
AstraZeneca's application to expand Tagrisso indication in Japan granted priority review
Read More
Novel 5-HT7 receptor agonists identified at the Institute of Pharmacology
Read More
Astellas divulges new melanocortin MC4 receptor agonists
Read More
Roche profiles pipeline progress of fourth quarter 2017
Read More
Synairgen initiates phase II trial of inhaled SNG-001 in COPD
Read More
STAT3 shown as potential therapeutic target for gastroenteropancreatic neuroendocrine tumors
Read More
NetVation DL Medicine, Pfizer enter research collaboration
Read More
ContraVir Pharmaceuticals' TXL safe, well tolerated in phase I study
Read More
Durvalumab/tremelimumab/nab-paclitaxel/gemcitabine regimen well tolerated in metastatic PDAC
Read More
Imugene reports early data from trial of IMU-131 in metastatic gastric cancer
Read More
Janssen and Theravance establish collaboration on TD-1473 for inflammatory intestinal diseases
Read More
Targovax completes safety lead-in of phase I/II trial of ONCOS-102 in mesothelioma
Read More